Canadian scientists set about testing an experimental drug for Huntington’s disease in humans.
It is reported that this drug is the first medicine in the long term able to help in the fight against Huntington's syndrome. The substance, code-named IONIS-HTTRx, has already been successfully tested in laboratory mice and monkeys. During animal experiments, the wards with Huntington's disease returned to normal after two months of treatment.
"Human" therapy consists of four courses of injections, the intervals between courses last one month. The drug is injected into the spinal fluid of the patient. The drug contributes to the "silencing" of the gene responsible for creating the protein that causes the breakdown of the nervous system. The disease is accompanied by chaotic movements, impaired cognitive functions, irreversible changes in character.
In mass culture, Huntington's disease became known after the release of the popular TV series "House House" with the title role. The mentioned symptom was found in the assistant of the protagonist, whose role she played.